Skip to main content
. 2020 Feb 5;5(6):2967–2977. doi: 10.1021/acsomega.9b03906

Table 1. Antibodies Used in the Present Study.

antibody introduction and company dilution ratio
PCNA #2586, Cell Signaling Technology 1:1000
cleaved caspase3 ab184787, Abcam 1:1000
TLR4 sc-293072, Santa Cruz 1:200
MyD88 #AB32107, AbSci 1:2000
Phospho-NF-kB p65 #3033, Cell Signaling Technology 1:1000
iNOS ab178945, Abcam 1:1000
CD163 ab182422, Abcam 1:1000
TGF-β1 ab92486, Abcam 1:1000
Smad3 ab40854, Abcam 1:1000
phospho-Smad3 ab52903, Abcam 1:1000
α-SMA ab18147, Abcam 1:1000
E-cadherin ab76055, Abcam 1:1000
GAPDH ap0066, Bioworld 1:10,000